$16.45 -0.20 (-1.20%)
11/27/2009 1:00 PM

XenoPort, Inc. (XNPT)

CAPS Rating: 2 out of 5

A biopharmaceutical company focused on developing a portfolio of internally discovered product candidates that utilize the body's natural nutrient transporter mechanisms to improve the therapeutic benefits of drugs.

Featured Broker Partners